Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 253
7
Diseases
7
Unique genes
0.333
Avg. similarity score
Axenfeld anomaly
Most-connected disease (6 links)
Disease
Searched: FOXC1-related anterior segment dysgenesis
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
FOXC1-related anterior segment dysgenesis
Axenfeld anomaly
Iridogoniodysgenesis
Rieger syndrome
Axenfeld-rieger syndrome
Ring dermoid of cornea
anterior segment dysgenesis 4
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Axenfeld anomaly | 6 | 6 | 2 |
| Iridogoniodysgenesis | 6 | 6 | 2 |
| Rieger syndrome | 6 | 6 | 4 |
| Axenfeld-rieger syndrome | 4 | 4 | 6 |
| FOXC1-related anterior segment dysgenesis | 4 | 4 | 1 |
| Ring dermoid of cornea | 4 | 4 | 1 |
| anterior segment dysgenesis 4 | 4 | 4 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| PITX2 | 6 / 7 | anterior segment dysgenesis 4, Axenfeld anomaly, Axenfeld-rieger syndrome, Iridogoniodysgenesis and 2 more |
| FOXC1 | 5 / 7 | Axenfeld anomaly, Axenfeld-rieger syndrome, FOXC1-related anterior segment dysgenesis, Iridogoniodysgenesis and 1 more |
| COL4A1 | 2 / 7 | Axenfeld-rieger syndrome, Rieger syndrome |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Hedgehog 'off' state | Reactome | 2 / 56 | 61.3× | 4.42e-4 | 7.53e-3 ✓ sig. |
| TFAP2 (AP-2) family regulates transcription of other transcription factors | Reactome | 1 / 4 | 429× | 2.33e-3 | 2.65e-2 ✓ sig. |
| Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) | Reactome | 1 / 7 | 245× | 4.07e-3 | 3.93e-2 ✓ sig. |
| Ligand-receptor interactions | Reactome | 1 / 7 | 245× | 4.07e-3 | 3.93e-2 ✓ sig. |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | Reactome | 1 / 14 | 123× | 8.13e-3 | 6.22e-2 |
| Extracellular matrix organization | Reactome | 1 / 15 | 114× | 8.71e-3 | 6.50e-2 |
| Anchoring fibril formation | Reactome | 1 / 15 | 114× | 8.71e-3 | 6.50e-2 |
| Activation of SMO | Reactome | 1 / 18 | 95.3× | 1.04e-2 | 7.29e-2 |
| Crosslinking of collagen fibrils | Reactome | 1 / 18 | 95.3× | 1.04e-2 | 7.29e-2 |
| NCAM1 interactions | Reactome | 1 / 21 | 81.7× | 1.22e-2 | 8.02e-2 |
| Non-integrin membrane-ECM interactions | Reactome | 1 / 24 | 71.5× | 1.39e-2 | 8.64e-2 |
| Maturity onset diabetes of the young | KEGG | 1 / 26 | 66.0× | 1.51e-2 | 9.07e-2 |
| Laminin interactions | Reactome | 1 / 28 | 61.3× | 1.62e-2 | 9.49e-2 |
| Signaling by PDGF | Reactome | 1 / 33 | 52.0× | 1.91e-2 | 1.04e-1 |
| Collagen chain trimerization | Reactome | 1 / 44 | 39.0× | 2.54e-2 | 1.22e-1 |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| brain development | GO:0007420 | 4 / 244 | 43.8× | 9.63e-7 | 8.18e-5 ✓ sig. |
| camera-type eye development | GO:0043010 | 3 / 74 | 108× | 2.06e-6 | 1.52e-4 ✓ sig. |
| lacrimal gland development | GO:0032808 | 2 / 7 | 763× | 2.52e-6 | 1.80e-4 ✓ sig. |
| neural tube patterning | GO:0021532 | 2 / 8 | 667× | 3.36e-6 | 2.26e-4 ✓ sig. |
| iris morphogenesis | GO:0061072 | 2 / 9 | 593× | 4.32e-6 | 2.75e-4 ✓ sig. |
| negative regulation of transcription by RNA polymerase II | GO:0000122 | 5 / 1,002 | 13.3× | 8.42e-6 | 4.74e-4 ✓ sig. |
| animal organ morphogenesis | GO:0009887 | 3 / 130 | 61.6× | 1.13e-5 | 5.94e-4 ✓ sig. |
| embryonic camera-type eye development | GO:0031076 | 2 / 15 | 356× | 1.26e-5 | 6.46e-4 ✓ sig. |
| cell fate determination | GO:0001709 | 2 / 18 | 297× | 1.84e-5 | 8.67e-4 ✓ sig. |
| anatomical structure morphogenesis | GO:0009653 | 3 / 160 | 50.1× | 2.10e-5 | 9.64e-4 ✓ sig. |
| regulation of smoothened signaling pathway | GO:0008589 | 2 / 29 | 184× | 4.86e-5 | 1.82e-3 ✓ sig. |
| pituitary gland development | GO:0021983 | 2 / 30 | 178× | 5.21e-5 | 1.92e-3 ✓ sig. |
| limb morphogenesis | GO:0035108 | 2 / 31 | 172× | 5.56e-5 | 2.02e-3 ✓ sig. |
| branching involved in blood vessel morphogenesis | GO:0001569 | 2 / 33 | 162× | 6.32e-5 | 2.21e-3 ✓ sig. |
| in utero embryonic development | GO:0001701 | 3 / 252 | 31.8× | 8.15e-5 | 2.70e-3 ✓ sig. |